Analystreport

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com